M&A Deal Summary

IQVIA Acquires Advion

On October 27, 2011, IQVIA acquired life science company Advion from Aisling Capital

Acquisition Highlights
  • This is IQVIA’s 4th transaction in the Life Science sector.
  • This is IQVIA’s 7th transaction in the United States.
  • This is IQVIA’s 1st transaction in New York.

M&A Deal Summary
Date 2011-10-27
Target Advion
Sector Life Science
Buyer(s) IQVIA
Sellers(s) Aisling Capital
Deal Type Add-on Acquisition

Target

Advion

Ithaca, New York, United States
Advion is a leading provider of bioanalytical services to the pharmaceutical industry, and a developer of automated, chip-based technology designed to boost the sensitivity, data quality and sample throughput for electrospray mass spectrometers

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

IQVIA

Durham, North Carolina, United States
Category Company
Sector Life Science
Employees87,000
Revenue 15.0B USD (2023)
DESCRIPTION
Quintiles office in San Diego, California.
Quintiles office in San Diego, California.

IQVIA is a provider of advanced analytics, technology solutions, and contract research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. IQVIA was founded in 2016 and is based in Durham, North Carolina.

DEAL STATS #
Overall 8 of 18
Sector (Life Science) 4 of 8
Type (Add-on Acquisition) 7 of 15
State (New York) 1 of 2
Country (United States) 7 of 15
Year (2011) 4 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-10-19 Outcome Sciences

Cambridge, Massachusetts, United States

Outcome Sciences, Inc. is a provider of observational research services. Observational research encompasses registries, post-approval research and quality improvement initiatives across multiple healthcare stakeholders (biopharmaceutical, medical device, government and providers).

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-11-07 Advion BioServices

Ithaca, New York, United States

Advion BioServices, Inc. is a premier U.S.-based bioanalytical laboratory. Company provides Good Laboratory Practice (GLP) pharmacokinetic/pharmacodynamic (PK/PD) testing and other services to biopharma companies worldwide.

Buy -

Seller(S) 1

SELLER

Aisling Capital

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2000
PE ASSETS 1.8B USD
Size Large
Type Sector Focused
DESCRIPTION

Aisling Capital is a private investment firm focused on opportunities in the healthcare and medical technology sectors. The Firm specifically looks to invest in companies developing and commercializing innovative healthcare products, services, and technologies. Aisling Capital looks to commit $20 to $50 million per investment and prefers to be the lead investor. Aisling will consider investing in both public and private companies. Aisling Capital raised its first fund in 2000. The Firm is based in New York City.

DEAL STATS #
Overall 17 of 41
Sector (Life Science) 15 of 32
Type (Add-on Acquisition) 16 of 24
State (New York) 4 of 7
Country (United States) 17 of 41
Year (2011) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-10-25 ZELTIQ Aesthetics

Pleasanton, California, United States

ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting® System, is designed to reduce unwanted fat. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-03-12 LensAR

Orlando, Florida, United States

LensAR, Inc. is a medical device company developing lasers for ophthalmic applications.

Buy $24M
Mergr

Product

Company

Legal